arrow
A

Alfredo Rivas-Delgado

Memorial Sloan Kettering Cancer Center
H指数:24
被引数:1,844

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical outcomes, patterns of relapse and molecular landscape of advanced stage High Grade B-cell Lymphoma

晚期高级别B细胞淋巴瘤的临床结局、复发模式和分子景观

2026-07-130
OA
Landmark-Based Evaluations of Long-Term Outcomes After CD19 CAR T-cell Therapy in Large B-Cell Lymphoma

基于里程碑的CD19 CAR T细胞疗法后大型B细胞淋巴瘤的长期预后评估

2026-02-280
PRE
Towards Personalized Lymphodepletion: A Population Pharmacokinetic Fludarabine Model in Patients Receiving CAR T-Cell Therapy

迈向个性化淋巴细胞清除:接受CAR T细胞疗法的患者群体药代动力学氟达拉滨模型

2025-12-100
OA
Patterns and safety of glucocorticosteroid use following CD19 CAR-T therapy for large B-cell lymphoma

CD19 CAR-T疗法后大B细胞淋巴瘤患者糖皮质激素使用模式与安全性

2025-11-010
OAAI
Comparative real-world outcomes of CD19-directed CAR T-cell therapies in large B-cell lymphoma

CD19靶向CAR T细胞疗法在大型B细胞淋巴瘤中的比较真实世界结果

2025-08-190
OAAI
Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms

特定疾病的U1剪接体RNA突变在成熟B细胞肿瘤中

Leukemia
IF13.4
2025-06-300
OAAI
Tumor Determinants of Response to CAR-T Therapy in Relapsed or Refractory Mantle Cell Lymphoma

弥漫大B细胞淋巴瘤复发或难治性情况下对CAR-T疗法的肿瘤决定因素

BLOOD
IF23.1
2024-11-050
PRE
Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes

具有MYC,BCL2和/或BCL6重排的有限阶段高级别b细胞淋巴瘤: BCL2重排导致不良结果

2024-10-140
OAAI
Testicular large B-cell lymphoma is genetically similar to PCNSL and distinct from nodal DLBCL
2024-10-070
OAAI
Rituximab and lenalidomide for the treatment of relapsed or refractory indolent non-Hodgkin lymphoma: real-life experience

利妥昔单抗和来那度胺治疗复发或难治性惰性非霍奇金淋巴瘤的现实经验

2024-09-050
OAAI
A low total metabolic tumor volume independently predicts for a longer time to first treatment in initially observed, low tumor burden follicular lymphoma
2023-11-094
OAAI
Unraveling the genetics of transformed splenic marginal zone lymphoma
2023-07-1813
OAAI
Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviors
2023-03-309
OAAI
Detection of early seeding of Richter transformation in chronic lymphocytic leukemia
2022-08-1174
OAAI
NR1H3 (LXRα) is associated with pro-inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b-cell lymphoma
2022-08-099
OAAI
Serum soluble CD23 levels are an independent predictor of time to first treatment in chronic lymphocytic leukemia

血清可溶性CD23水平是慢性淋巴细胞白血病首次治疗时间的独立预测指标

2022-05-280
PRE
Oncogenic Vav1-Myo1f induces therapeutically targetable macrophage-rich tumor microenvironment in peripheral T cell lymphoma
2022-04-0115
OAAI